India Globalization Capital, Inc. India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments.  The company was by Ram Mukunda on April 29, 2005 and is headquartered in Bethesda, MD.
